According to SurModics's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2022 the company made a revenue of $0.10 B a decrease over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.13 B | 35.65% |
2022 | $0.10 B | -3.74% |
2021 | $0.10 B | 11.95% |
2020 | $94.54 M | -5.88% |
2019 | $0.10 B | 16.04% |
2018 | $86.56 M | 19.62% |
2017 | $72.36 M | -0.31% |
2016 | $72.58 M | 13% |
2015 | $64.23 M | 11.2% |
2014 | $57.76 M | 2.84% |
2013 | $56.16 M | 4.27% |
2012 | $53.86 M | -2.78% |
2011 | $55.4 M | -14.82% |
2010 | $65.03 M | -14.08% |
2009 | $75.69 M | -44.52% |
2008 | $0.13 B | 70.01% |
2007 | $80.25 M | 14.39% |
2006 | $70.15 M | 8.31% |
2005 | $64.77 M | 25.25% |
2004 | $51.72 M | 9.41% |
2003 | $47.27 M | 50.18% |
2002 | $31.47 M | 30.94% |
2001 | $24.04 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 67,208.23% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | 28,921.80% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | $42.85 B | 30,910.18% | ๐บ๐ธ USA |
Agilent Technologies A | $6.73 B | 4,773.27% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | 2,329.36% | ๐บ๐ธ USA |
Alkermes ALKS | $1.66 B | 1,103.60% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | $90.12 M | -34.79% | ๐บ๐ธ USA |
Heron Therapeutics HRTX | $0.12 B | -8.07% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $12.8 M | -90.73% | ๐บ๐ธ USA |